MedTrace Logo

The Acute Cardiovascular Effects of Nicotine in E-cigarettes (ACE) Study

NCT03010995 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2018-07-26

No results posted yet for this study

Summary

The goal of this project is to evaluate the nicotine induced acute cardiovascular changes in E-Cigarette users and also study the mechanism involved particularly with vascular impairment.

Conditions

  • Cigarette Smoking Toxicity
  • Nicotine
  • Acute Cardiovascular Disease

Interventions

DRUG

Prazosin

Prazosin will used to study the mechanism involved in nicotine induced acute cardiovascular changes

Sponsors & Collaborators

  • University of Louisville

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-03-13
Primary Completion
2018-07-24
Completion
2018-07-24
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03010995 on ClinicalTrials.gov